Decreased cerebrospinal fluid Aβ 38, 40, 42, and 43 levels in sporadic and hereditary cerebral amyloid angiopathy

De Kort et al. Ann Neurol. Jun 2023 doi:10.1002/ana.26610

Previous PostEvaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
Next PostPlasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays